Scribd
Upload
6 views2 pages

HbA1c Test Results and Interpretation

Mr. Mihir Majhi, a 57-year-old male, has an HbA1c level of 8.4%, indicating diabetes according to the American Diabetes Association criteria. The report recommends monitoring glycemic control through alternative tests like fructosamine due to potential inaccuracies from shortened RBC lifespan or abnormal hemoglobin variants. The sample was collected on January 5, 2026, and processed on January 6, 2026.

Uploaded by

infotech.ritta
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
6 views2 pages

HbA1c Test Results and Interpretation

Mr. Mihir Majhi, a 57-year-old male, has an HbA1c level of 8.4%, indicating diabetes according to the American Diabetes Association criteria. The report recommends monitoring glycemic control through alternative tests like fructosamine due to potential inaccuracies from shortened RBC lifespan or abnormal hemoglobin variants. The sample was collected on January 5, 2026, and processed on January 6, 2026.

Uploaded by

infotech.ritta
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Name : Mr. MIHIR MAJHI Patient UID.

: 10841610
Age/Gender : 57 Yrs/Male Visit No. : 0478626010500001
Referred Client : LDPLW3387-LDPL - CP Collected on : 05-Jan-2026 05:41PM
Referred By : NA Received on : 05-Jan-2026 10:47PM
Doctor Name : Dr. S ROY MD Reported on : 06-Jan-2026 01:47AM
Sample Type : Whole Blood EDTA - W3752801

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
HBA1C -GLYCOSYLATED HEMOGLOBIN WITH GRAPH
HbA1c 8.40 % Normal <5.7%
Methodology: HPLC Prediabetes 5.7% to 6.4%
Diabetes 6.5% or higher
ESTIMATED AVERAGE GLUCOSE(eAG) 194.38
Methodology: Calculated
INTERPRETATION
AS PER AMERICAN DIABETES ASSOCIATION (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years < 5.7
At risk (Prediabetes) 5.7 - 6.4

Diagnosing Diabetes >= 6.5

CLINICAL NOTES
In vitro quantitative determination of HbA1c in whole blood is utilized in long term monitoring of [Link] HbA1c level correlates with the mean glucose concentration
prevailing in the course of the patient's recent history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia monitoring than do
determinations of blood glucose or urinary glucose. It is recommended that the determination of HbA1c be performed at intervals of 4-6 weeks during Diabetes Mellitus
therapy. Results of HbA1c should be assessed in conjunction with the patient's medical history, clinical examinations and other findings.

Note:
[Link] RBC life span –HbA1c test will not be accurate when a person has a condition that affects the average lifespan of red blood cells (RBCs), such as hemolytic
anemia or blood loss. When the lifespan of RBCs in circulation is shortened, the A1c result is falsely low and is an unreliable measurement of a person's average glucose
over time.
[Link] forms of hemoglobin – The presence of some hemoglobin variants, such as hemoglobin S in sickle cell anemia, may affect certain methods for measuring A1c. In
these cases, fructosamine can be used to monitor glucose control.

Advised:
[Link] follow patient for glycemic control test like fructosamine or glycated albumin may be performed instead.
[Link] HPLC screen to analyze abnormal hemoglobin variant.
estimated Average Glucose (eAG) : estimated Average Glucose (eAG) based on value calculated according to National Glycohemoglobin Standardization Program
(NGSP) criteria.

*** End Of Report ***

Page 1 of 1
HbA1c Report

Sample Id : W3752801 Sample Processed Date: 06/01/2026 / 00:24:55

Peak Name Retention Time(s) Absorbance Area Result (Area %)

Hba1a 11 0.0044 0.158 0.8


Hba1b 13 0.0058 0.195 1.0
HbF 18 0.0037 0.136 0.7
La1c 27 0.0094 0.583 2.9
HbA1c 39 0.0169 1.35 8.4
HbA0 69 0.4265 16.949 83.8

HbA1c(NGSP)= 8.4 TotalArea= 19.371

You might also like